Article
Sunday, April 25, is also Symposia Day at ARVO, and a series of sessionsof broad scientific interest is being offered in the morning and afternoon.
Stealth BioTherapeutics reaches 50 percent enrollment target in phase 3 ReNEW study
California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
Case report: Bilateral retinal detachments in a 19-year-old
Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025
ARVO announces Swathi Kaliki, MD, as recipient of 2025 Ludwig von Sallmann Clinician-Scientist Award
Unity Biotechnology announces upcoming trial data and new board of directors member